Advances in antiviral therapy in dermatology.
For years, investigators have sought to control viral transmission and to find appropriate treatment for people who have viral infections. Exposure control (e.g. vaccines, sanitation, vector control, blood testing, condoms/abstinence, and education) has been extremely important in management of viral spread. Several antiviral agents have received approval from the United States Food and Drug Administration over the past few years. There continues to be extensive research on new antiviral agents as well as new vaccines to control viral disease and spread. Most viral diseases continue to be treated symptomatically; however, the discovery of new and improved antiviral agents has added great power to our ability to treat certain hard-to-control viruses that plague patients.
Evans
T Y
TY
Department of Dermatology Microbiology and Immunology, University of Texas Medical Branch at Galveston, USA.
Tyring
S K
SK
D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy; D006558:Herpes Genitalis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D030361:Papillomavirus Infections / Q000188:drug therapy; D011379:Prognosis; D011480:Protease Inhibitors / Q000627:therapeutic use; D017193:Skin Diseases, Viral / Q000188:drug therapy*; D014412:Tumor Virus Infections / Q000188:drug therapy
D000998:Antiviral Agents; D011480:Protease Inhibitors